Shaping tomorrow's health with you.

Secretarial office

+41 22 719 76 97

Consultations by appointment only.


Monday
08:30 - 11:30
14:00 - 16:30
Tuesday
08:30 - 11:30
14:00 - 16:30
Thursday
08:30 - 11:30
14:00 - 16:30
Friday
08:30 - 11:30
14:00 - 16:30
Dr

Sarah Malacarne

Head of Endocrinology & Diabetes Department
Specialist in Endocrinology & Diabetes and General Internal Medicine, Member of the Swiss Medical Association (FMH)
  • Information
  • Career
  • Training
  • Research and publications

Place of work

  • Hôpital de La Tour
    Bâtiment B2
    Avenue J.-D. Maillard 3
    CH-1217 Meyrin, Switzerland

Medical specialisms

Languages spoken

  • French
  • English

Professional activities

Since 2016
Head of Diabetes Department Hôpital de La Tour, Geneva, Switzerland
2010 - 2016
Junior doctor then Chief resident in the Endocrinology & Diabetes Department under Prof J. Philippe at Geneva University Hospitals. Supervision of consultations for diabetic foot care. Geneva University Hospitals, Geneva, Switzerland
2001 - 2010
Junior doctor then Chief resident in the Internal Medicine Department under Prof. A. Perrier. Geneva University Hospitals, Geneva, Switzerland

Studies and qualifications

2001
Medical degree Geneva, Switzerland
2007
FMH accredited in Internal Medicine Geneva, Switzerland
2013
FMH accredited in Endocrinology & Diabetes Geneva, Switzerland

Publication

2018
A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection BMC Infectious Diseases 2018
2016
Prévention des complications du pied diabétique, revue médicale suisse 2016;1092-1096
2015
Pied diabétique infecté : du diagnostic à la prise en charge. Revue médicale suisse 2015;1238-1241
2011
L’importance de la décharge dans le traitement des ulcères du pied diabétique. Revue médicale suisse 2011;1267-1272, editorial board award 2012
2007
Renal ischaemic injuries during the use of zolmitriptan for treatment of migraines in a transplanted patient under tacrolimus therapy. Nephrology, dialysis and transplantation, 2007; 22 (11): 3341-3343